
- /
- Supported exchanges
- / SHG
- / 603108.SHG
Shanghai Runda Med Tech Co (603108 SHG) stock market data APIs
Shanghai Runda Med Tech Co Financial Data Overview
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technical services; and logistic services. In addition, it is involved in the software development; provision of information system integration and consulting services; sale of chemicals; rental services; sale of medical devices; maintenance of electronic and mechanical equipment; import and export of technology; offers general cargo warehousing and road freight transportation services; and wholesale of medicines. The company was incorporated in 1999 and is headquartered in Shanghai, China.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Shanghai Runda Med Tech Co data using free add-ons & libraries
Get Shanghai Runda Med Tech Co Fundamental Data
Shanghai Runda Med Tech Co Fundamental data includes:
- Net Revenue: 8 433 M
- EBITDA: 828 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-04-19
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shanghai Runda Med Tech Co News

RPT-FOCUS-Zero-COVID, big money: China's anti-virus spending boosts medical, tech, construction
(Repeats story published earlier on Monday as FOCUS) By Eduardo Baptista BEIJING, May 30 (Reuters) - China's 'zero-COVID' policy of constantly monitoring, testing and isolating its citizens to preve...


Zero-COVID, big money: China's anti-virus spending boosts medical, tech, construction
By Eduardo Baptista BEIJING (Reuters) -China's 'zero-COVID' policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the count...

Zero-COVID, big money: China's anti-virus spending boosts medical, tech, construction
By Eduardo Baptista BEIJING, May 30 (Reuters) - China's 'zero-COVID' policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.